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Five new organotin(IV) complexes of 2-hydroxyacetophenone-2-methylphenylthiosemicarbazone [H2dampt, (1)] with formula
[RSnCln−1(dampt)] (where R = Me, n = 2( 2); R = Bu, n = 2( 3); R = Ph, n = 2( 4); R = Me2, n = 1( 5); R = Ph2, n = 1( 6)) have
been synthesized by direct reaction of H2dampt (1) with organotin(IV) chloride(s) in absolute methanol. The ligand (1) and its
organotin(IV) complexes (2–6) were characterized by CHN analyses, molar conductivity, UV-Vis, FT-IR, 1H, 13C, and 119Sn NMR
spectral studies. H2dampt (1) is newly synthesized and has been structurally characterized by X-ray crystallography. Spectroscopic
data suggested that H2dampt (1) is coordinated to the tin(IV) atom through the thiolate-S, azomethine-N, and phenoxide-O
atoms; the coordination number of tin is ﬁve. The in vitro antibacterial activity has been evaluated against Staphylococcus aureus,
Enterobacter aerogenes, Escherichia coli,a n dSalmonella typhi. The screening results have shown that the organotin(IV) complexes
(2–6) have better antibacterial activities and have potential as drugs. Furthermore, it has been shown that diphenyltin(IV)
derivative (6) exhibits signiﬁcantly better activity than the other organotin(IV) derivatives (2–5).
1.Introduction
Thiosemicarbazones and their metal complexes have
received considerable attention in chemistry and biology,
primarily because of their marked and various biological
properties [1–3]. The pharmacological proﬁles of 2-formyl,
2-acetyl, and 2-benzoylpyridine thiosemicarbazones have
been investigated [4]. Seena and Kurup [5] have synthesized
and characterized dioxomolybdenum(IV) complexes with
2-hydroxyacetophenone-N(4)-cyclohexyl and N(4)-phenyl
thiosemicarbazone which suggested that the Mo(IV)
complex is pentacoordinated [5]. For the past few years,
studies of the coordination chemistry of thiosemicarbazone
involved complexes with transition metal ions [6–8].
Organotin(IV) complexes have been the subject of interest
for some time because of their biomedical and commercial
applications including in vitro and in vivo antitumor activity
[9, 10]. Many organotin(IV) complexes have been found to
be as eﬀective as or even better than traditional anticancer
drugs [11–14]. Organotin(IV) chelates with nitrogen, sulfur,
and oxygen donor ligands have gained attention during
the last few years [15]. The coordination chemistry of
tin is extensive with various geometries and coordination
numbers known for both inorganic and organometallic
complexes [16, 17]. In our previous work, we have reported
some new organotin(IV) complexes with heterocyclic-
N(4)-cyclohexylthiosemicarbazone ligands [18, 19]. The
results revealed that thiosemicarbazones derived from
2-benzoylpyridine and 2-acetylpyrazine and their tin
(IV)/organotin(IV) complexes have been characterized
by diﬀerent spectroscopic techniques. From the
literature survey, the studies on the organotin(IV)
complexes derived from substituted thiosemicarbazone
ligands con-taining ONS-donor atoms are still lacking.2 Bioinorganic Chemistry and Applications
To the best of our knowledge, there was no report on the
organotin(IV) complexes of the 2-hydroxyacetophenone-
2-methylphenylthiosemicarbazone. In this view, we have
synthesized a series of organotin(IV) complexes with 2-
hydroxyacetophenone-2-methylphenylthiosemicarbazone.
These complexes have been characterized by elemental
analysis, 1H, 13C, and 119Sn NMR spectroscopy. X-ray crystal
structure of 2-hydroxyacetophenone-2-methylphenylthi-
osemicarbazone (1) is also described. Their biological ac-
tivity data has also been reported.
2. Experimental
2.1. Materials and Methods. All reagents were purchased
from Fluka, Aldrich, and JT Baker. All solvents were puriﬁed
according to standard procedures [20]. UV-Vis spectra were
recorded in CHCl3 solution with a Perkin Elmer Lambda
25 UV-Visible spectrometer. Infrared spectra were recorded
on KBr discs using a Perkin Elmer Spectrum GX Fourier-
Transformspectrometerintherange4000–370cm−1 atroom
temperature. 1H, 13C, and 119Sn NMR spectra were recorded
on a JEOL 500MHz-NMR spectrometer; chemical shifts
were given in ppm relative to SiMe4 and SnMe4 in CDCl3
solvent. CHN analyses were obtained with a Flash EA 1112
series CHN elemental analyzer. Molar conductivity measure-
ments were carried out with Jenway 4510 conductivity meter
using DMF solvent mode.
2.2. Synthesis of 2-Hydroxyacetophenone-2-Methylphenylthi-
osemicarbazone (H2dampt) (1). The 2-methylphenylisothi-
ocyanate (0.746g, 5mmol) and hydrazine hydrate (0.253g,
5mmol), each dissolved in 10mL ethanol, were mixed with
constant stirring. The stirring was continued for 30min
and the white product, 2-meth-ylphenylthiosemicarbazide,
formed was washed with ethanol and dried in vacuo.A
solution of the isolated 2-methylphenylthiosemicarbazide
(0.540g, 3mmol) in 10mL methanol was then reﬂuxed with
a methanolic solution of 2-hydroxyacetophenone (0.408g,
3mmol) for 5h after adding 1-2 drops of glacial acetic
acid (Scheme 1). On cooling the solution to room temper-
ature, light-yellow microcrystals were separated and washed
with methanol. The microcrystals were recrystallized from
methanol and dried in vacuo over silica gel. Yield: 0.74g,
78%: M.p.: 178–180◦C: UV-Visible (CHCl3) λmax/nm: 226,
318, 359: FT-IR (KBr disc, cm−1) νmax: 3175 (s, OH), 3000 (s,
NH), 1583 (m, C=N), 1298 (m, C–O), 943 (m, N–N), 1371,
861 (w, C=S). 1HN M R( C D C l 3) δ: 10.82 (s, 1H, OH), 9.02
(s, 1H, N–H), 7.31–7.25 (m, 8H, phenyl ring), 2.56 (s, 3H,
N=C–CH3), 2.29 (s, 3H, CH3), 1.19 (s, 1H, SH). 13CN M R
(CDCl3) δ: 185.20 (NH–C=S), 165.32 (C=N), 145.30–136.21
(aromatic ring), 10.45 (CH3). Anal. Calc. for C16H17N3OS:
C, 64.21; H, 5.73; N, 14.04%. Found: C, 64.17; H, 5.67; N,
14.01%.
2.3. Synthesis of [MeSnCl(dampt)] (2). H2dampt (0.299g,
1.0mmol) was dissolved in absolute methanol (10mL) in a
Schlenk round bottom ﬂask under a nitrogen atmosphere.
Then, a methanolic solution of methyltin(IV) trichloride
(0.24g, 1.0mmol) was added dropwise. The resulting reac-
tion mixture was reﬂuxed for 4h (Scheme 2)a n dc o o l e d
to room temperature. The microcrystals were ﬁltered oﬀ,
washed with a small amount of cold methanol, and dried
in vacuo over silica gel. Yield: 0.41g, 76 %: Mp.: 222–224◦C:
Molar conductance (DMF) Ω−1cm2 mol−1:7 . 1 :U V - V i s i b l e
(CHCl3) λmax/nm: 262, 328, 367, 384: FT-IR (KBr, cm−1)
νmax: 3378 (s, NH), 1595 (m, C=N–N=C), 1268 (m, C–O),
1026 (w, N–N), 1306, 822 (m, C–S), 612 (w, Sn–C), 570 (w,
Sn–O), 449 (w, Sn–N). 1H NMR (CDCl3,
2J[119Sn, 1H]) δ:
9.08 (s, 1H, N–H), 7.26–6.94 (m, 8H, phenyl ring), 2.95 (s,
3H, N=C–CH3), 2.30 (s, 3H, CH3), 1.09 (s, 3H, Sn–CH3),
[74.4Hz]. 13C NMR (CDCl3) δ: 180.55 (N=C–S), 170.88
(C=N), 144.35–135.60 (aromatic ring), 18.70 (CH3), 12.80
(Sn–CH3). 119Sn NMR (CDCl3) δ: −168.5. Anal. Calc. for
C17H18N3SOSnCl: C, 43.76; H, 3.88; N, 9.00%. Found: C,
43.71; H, 3.82; N, 8.95%.
The other complexes (3–6) were synthesized using
a similar procedure to organotin(IV) complex (2) using
appropriate organotin(IV) chloride(s) (Scheme 2).
2.4. Synthesis of [BuSnCl(dampt)] (3). Yield: 0.43g, 74%:
Mp.:226–228◦C:Molarconductance(DMF)Ω−1cm2 mol−1:
9.1: UV-Visible (CHCl3) λmax/nm: 262, 328, 382, 397: FT-IR
(KBr, cm−1) νmax: 3374 (s, NH), 1599 (m, C=N–N=C), 1254
(m, C–O), 1014 (w, N–N), 1299, 835 (m, C–S), 605 (w, Sn–
C), 568 (w, Sn–O), 443 (w, Sn–N). 1HN M R( C D C l 3) δ:9 . 0 7
(s, 1H, N–H), 7.25–7.97 (m, 8H, phenyl ring), 2.62 (s, 3H,
N=C–CH3), 2.30 (s, 3H, CH3), 2.28–2.15 (t, 2H, Sn–CH2–
CH2–CH2–CH3), 2.14–1.73 (m, 2H, Sn–CH2–CH2–CH2–
CH3), 1.24–1.22 (m, 2H, Sn–CH2–CH2–CH2–CH3), 0.99–
0.86 (t, 3H, Sn–CH2–CH2–CH2–CH3). 13CN M R( C D C l 3)
δ: 178.99 (N=C–S), 168.36 (C=N), 145.20–136.22 (aromatic
ring), 32.78, 26.31, 24.18, 20.11 (Sn–CH2–CH2–CH2–CH3),
16.44 (CH3). 119Sn NMR (CDCl3) δ: −149.6. Anal. Calc. for
C20H24N3SOSnCl: C, 45.10; H, 4.54; N, 7.88%. Found: C,
45.00; H, 4.51; N, 7.81%.
2.5. Synthesis of [PhSnCl(dampt)] (4). Yield: 0.48g, 79%:
Mp.:218–220◦C:Molarconductance(DMF)Ω−1cm2 mol−1:
3.11: UV-Visible (CHCl3) λmax/nm: 263, 335, 381, 410: FT-
IR (KBr, cm−1) νmax: 3184 (s, NH), 1598 (m, C=N–N=C),
1240 (m, C–O), 1035 (w, N–N), 1300, 838 (m, C–S), 601
(w, Sn–C), 522 (w, Sn–O), 471 (w, Sn–N). 1H NMR (CDCl3)
δ: 9.01 (s, 1H, N–H), 7.24-6.95 (m, 13H, phenyl ring), 2.76
(s, 3H, N=C–CH3), 2.29 (s, 3H, CH3). 13CN M R( C D C l 3)
δ: 180.12 (N=C–S), 173.97 (C=N), 144.84–136.60 (aromatic
ring), 16.88 (CH3). 119Sn NMR (CDCl3) δ: −174.73. Anal.
Calc. for C22H20N3SOSnCl: C, 49.98; H, 3.81; N, 7.94%.
Found: C, 48.92; H, 3.77; N, 7.90%.
2.6. Synthesis of [Me2Sn(dampt)] (5). Yield: 0.41g, 78%:
Mp.:210–212◦C:Molarconductance(DMF)Ω−1cm2 mol−1:
5.2: UV-Visible (CHCl3) λmax/nm: 266, 338, 378, 414: FT-
IR (KBr, cm−1) νmax: 3320 (s, NH), 1605 (m, C=N–N=C),
1252 (m, C–O), 1036 (w, N–N), 1300, 832 (m, C–S),
603 (w, Sn–C), 523 (w, Sn–O), 499 (w, Sn–N). 1HN M R
(CDCl3,
2J[119Sn, 1H]) δ:9 . 0 8( s, 1H, N–H), 7.26–6.94 (m,Bioinorganic Chemistry and Applications 3
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Scheme 1: Synthesis of 2-hydroxyacetophenone-2-methylphenylthiosemicarbazone (H2dampt) ligand (1).
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Scheme 2: Reaction scheme for the synthesis of organotin(IV) complexes (2–6).
8H, phenyl ring), 2.98 (s, 3H, N=C–CH3), 2.30 (s, 3H, CH3),
0.98 (s, 3H, Sn–CH3), [77.5Hz]. 13CN M R( C D C l 3,[1J( 13C–
119Sn]) δ: 181.10 (N=C–S), 178.45 (C=N), 145.68–137.20
(aromaticring),17.5(CH3),14.97(Sn–CH3)[557Hz]. 119Sn
NMR(CDCl3)δ:−182.45.Anal.Calc.forC18H21N3SOSn:C,
48.54; H, 4.74; N, 9.41%. Found: C, 48.50; H, 4.71 N, 9.38%.
2.7. Synthesis of [Ph2Sn(dampt)] (6). Yield: 0.48g, 75%:
Mp.:258–260◦C:Molarconductance(DMF)Ω−1cm2 mol−1:
8.17: UV-Visible (CHCl3) λmax/nm: 268, 327, 373, 402: FT-IR
(KBr, cm−1) νmax: 3383 (s, NH), 1592 (m, C=N–N=C), 1265
(m, C–O), 1039 (w, N–N), 1307, 821 (m, C–S), 601 (w, Sn–
C), 570 (w, Sn–O), 448 (w, Sn–N). 1HN M R( C D C l 3) δ:9 . 0 24 Bioinorganic Chemistry and Applications
(s, 1H, N–H), 7.30–6.97 (m, 13H, phenyl ring), 2.67 (s, 3H,
N=C–CH3), 2.29 (s, 3H, CH3). 13CN M R( C D C l 3,[ 1J( 13C–
119Sn]) δ: 179.98 (N=C–S), 171.75 (C=N), 142.20–138.21
(aromatic ring), 15.88 (CH3) [546Hz].119Sn NMR (CDCl3)
δ: −185.32.Anal.Calc.forC28H25N3SOSn:C,58.97;H,4.41;
N, 7.36%. Found: C, 58.92; H, 4.38; N, 7.30%.
2.8. Antibacterial Test. The synthesized ligand (1) and its
organotin(IV) complexes (2–6)w e r es c r e e n e din vitro for
their antibacterial activity against Staphylococcus aureus,
Enterobacter aerogenes, Escherichia coli, and Salmonella typhi
bacterial strains using agar-well diﬀusion method [21]. Wells
(size of well 6mm in diameter) were dug in the media
with the help of a sterile metallic borer with centers at
least 24mm. Eight-hour old bacterial inoculums containing
104–106 colony-forming units (CFU)/mL were spread on
the surface of the nutrient agar using a sterile cotton swab.
Recommended concentration of the test sample (200mg/mL
inDMSO)wasintroducedintherespectivewells.Otherwells
supplemented with DMSO and reference drug (doxycycline)
served as negative and positive controls, respectively. The
plates were incubated immediately at 37◦Cf o r2 0h .A c t i v i t y
was determined by measuring the diameter of zones showing
complete inhibition (mm). Growth inhibition was calculated
with reference to the positive control.
3. Results andDiscussion
3.1. Synthesis. 2-Hydroxyacetophenone-2-methylphenylthi-
osemicarbazone (H2dampt) was synthesized by the conden-
sation reaction of 2-hydroxyacetophenone and 2-methyl-
phenylthiosemicarbazide in absolute methanol in 1:1 mole
ratio. It has two tautomers within the structure, existing
as either thione or thiol tautomer (Scheme 1). The present
organotin(IV) complexes (2–6) were obtained by direct
reaction of organotin(IV) chloride(s) and H2dampt (1)i n
absolute methanol under N2 atmosphere (Scheme 2). The
physical properties and analytical data of H2dampt (1)
and its organotin(IV) complexes (2–6)a r eg i v e ni nt h e
experimental section. All complexes (2–6) were stable under
N2 atmosphereandsolubleinCHCl3,CH 2Cl2,DMF ,DMSO ,
and MeCN solvents except methanol, ethanol, hexane,
pentane, THF, and ether. The molar conductances values of
the complexes (2–6) are 9.1–3.1Ω−1cm2 mol−1,r e s p e c t i v e l y ,
indicate that the complexes behave as nonelectrolytes [22].
3.2. UV-Visible Spectra. T h eU V - V i ss p e c t r ao fl i g a n d( 1)
and its organotin(IV) complexes (2–6) were carried out
in CHCl3 (1 × 10−4 molL−1)a tr o o mt e m p e r a t u r e .T h e
free ligand (1) exhibited three absorption bands at 262,
318, and 359nm assigned to the HOMO/LUMO transi-
tion of phenolic group, azomethine, and thiolate function,
respectively [23]. After complexation, the UV-Vis spectra
of the complexes (2–6) exhibited four absorption bands in
the region at 262–268, 327–338, 367–382, and 384–414nm,
respectively. In the electronic spectra of the complexes (2–
6), the intraligand transition is shifted to higher wavelength
as a result of coordination. In the spectra of organotin(IV)
complexes (2–6), one new absorption band appeared at
384–414nm which is assigned to the ligand→metal charge
transfer (LMCT) [24]. The shift of the λmax band from the
ligand to the complex is supported by the coordination of
ligand (1) to the tin(IV) ion.
3.3. IR Spectra. T h eI Rs p e c t r u mo ff r e el i g a n d( 1) showed
absorption bands at 3175 and 3000cm−1,w h i c ha r ed u e
to the stretching vibrations of the OH and NH groups,
respectively. The absorption bands at 1583, 1298, 943, and
1371, 861cm−1are due to ν(C=N), ν(C–O), ν(N–N), and
ν(C=S), respectively. Several signiﬁcant changes with respect
to the free ligand (1) bands on complexation suggest coor-
dination through phenolic group, azomethine, and sulfur
of the thiolic form of the ligand. The strong stretching
band at 3375cm−1 that corresponds to the ν(OH) group in
the spectrum of ligand (1) has disappeared in the spectra
of complexes (2–6) due to the deprotonation, indicating
coordination through the phenolic oxygen to tin(IV) atom.
T h ef r e el i g a n d( 1) showed a band at 1298cm−1 which is due
to ν(C–O). This band is shifted to lower wave numbers at
1240–1268cm−1 inthecomplexes(2–6),indicatingthecoor-
dination of O− to the tin(IV) atom [25]. The newly formed
ν(C=N–N=C) bond showed medium-to-strong absorption
peaks in the range at 1592–1605cm−1 in the spectra of
the complexes (2–6), indicating coordination of azomethine
nitrogen to tin(IV) atom [26]. A sharp band at 943cm−1
is due to ν(N–N) for ligand (1) is shifted to higher fre-
quencies at 1014–1039cm−1 in the spectra of organotin(IV)
complexes ((2–6). The increase in the frequency of this band
in the spectra of complexes (2–6) due to an increase in the
bond length again conﬁrms coordination viathe azomethine
nitrogen atom [27]. The bands at 1371 and 861cm−1 in
the free ligand (1)d u et oν(C=S) stretching vibrations are
shifted to lower frequencies at 1299–1307cm−1 and 821–
838cm−1 in the spectra of the complexes (2–6), suggesting
coordination through the thiolate sulfur with tin(IV) atom
[28]. The IR bands observed in the range at 570–522cm−1
in the spectra of the complexes (2–6) suggest the presence
of Sn–O bonding in their structure. The ν(Sn–C) and
ν(Sn–N) bands are tentatively assigned to absorptions in
the regions 612–601cm−1 and 443–499cm−1,r e s p e c t i v e l y .
Based on the infrared spectra analyses of ligand (1)a n d
its organotin(IV) complexes (2–6), it was suggested that
ligand (1) was coordinated to the tin(IV) core through the
phenoxide-O, azomethine-N, and thiolato-S atoms.
3.4. 1HN M RS p e c t r a . 1H NMR spectrum of free ligand (1)
showedresonancesignalsat10.82,9.02,7.31–7.25,2.56,2.29,
and 1.19ppm are due to OH, NH, phenyl ring protons,
N=C–CH3,C H 3, and SH, respectively. After complexation,
the resonance signal of OH proton was absent in the spectra
of the complexes (2–6), indicating deprotonation of the
phenolic proton and supported the phenolic oxygen atom
was coordinated with tin(IV) atom. The resonance signal
of SH is not found in the spectra of complexes (2–6)
which suggested the deprotonation of the SH proton and
conﬁrming that the ligand coordinated to the tin(IV) in theBioinorganic Chemistry and Applications 5
thiolate form. The azomethine proton (N=C–CH3) signal
appears at 2.56ppm in the free ligand (1) which is shifted
to high frequency at 2.98–2.62ppm in the complexes (2–
6), supporting the coordination of azomethine nitrogen to
the central tin(IV) atom. The resonance signals for the
protons of phenyl moiety of the ligand (1) were observed
at 7.31–7.25ppm, which is shifted to low frequency at
7.30–6.94ppm in the complexes (2–6). This is due to the
electron withdrawal tendency from the aromatic ring owing
to coordination with tin(IV). The methyl group attached to
the tin(IV) in complexes 2 and 5 gave a singlet at 1.09 and
0.98ppm with 2J[119Sn,1H] coupling constant value equal to
74.4and77.5Hz,respectively,supportingtheﬁve-coordinate
environment around tin(IV) [29]. The three butyl groups
attachedtothetin(IV)moityintheorganotin(IV)complex3
gave four resonance signals, namely, 2.28–2.15ppm (triplet,
Sn–CH2–CH2–CH2–CH3), 2.14–1.73ppm (multiplet, Sn–
CH2–CH2–CH2–CH3), 1.24–1.22ppm (multiplet, Sn–CH2–
CH2–CH2–CH3), and 0.99–0.86ppm (triplet, Sn–CH2–
CH2–CH2–CH3). 1H NMR information also supported the
IR data of the complexes (2–6).
3.5. 13CN M RS p e c t r a .The 13C-{1H} NMR spectrum of
free ligand (1) showed the resonance signals at 185.20,
165.32, 145.30–136.21, and 10.45ppm are due to the δ(NH–
C=S), δ(C=N), δ (aromatic ring carbon) and δ(CH3),
respectively. After complexation, the carbon signals of the
N=C–Sgroupshiftedtolowfrequencyat179.99–181.10ppm
in all the complexes (2–6) compared to ligand (1), indicating
participation of the N=C–S group in coordination to tin(IV)
atom. The chemical shifts of carbon in C=N and CH3 in
the free ligand (1) were observed at 165.32 and 10.45ppm
which were shifted to high frequency at 168.36–178.45 and
16.44–18.70ppm, respectively, in the complexes (2–6). This
results supported the azomethine-N is coordinated to the
tin(IV) atom [30]. After complexation, the δ value of carbon
atoms in the aromatic ring did not have much change
in the complexes (2–6) as compared to the free ligand.
Besides, the butyl group attached to the organotin(IV)
moiety in complex 3 gave four resonance signals at 32.78,
26.31, 24.18, and 20.11ppm. In the 13C-{1H} NMR spectra
of the organotin(IV) complexes 2 and 5, a sharp singlet
resonance signal appeared at 12.80ppm [(Sn–CH3)] and
14.97 [Sn–(CH3)2] ppm, respectively [31]. In organotin(IV)
compounds, the 1J[119Sn, 13C] value is an important param-
eter to assess the coordination number of the Sn atom. The
calculated coupling constants for dimethyltin(IV) (4) and
diphenyltin(IV) (5) compounds were found to be 557 and
546Hz, which described the penta-coordinate environment
about the Sn atom in these compounds [32]. All these
statements are also supported by the 1H NMR spectra
analyses.
3.6. 119Sn NMR Spectra. 119S nN M Rs p e c t r ac a nb eu s e da s
an indicator of the coordination number of the tin atom.
119Sn NMR of all the complexes (2–6) shows only one
resonance signals in the range of −149.60 to −185.32ppm.
119Sn NMR values are characteristic for the ﬁve-coordinated
Table 1: Summary of crystal data and structure reﬁnement
parameters for ligand (1).
Compound H2dampt (1)
Empirical formula C16H17N3OS
Formula weight 299.39
Temperature (K) 100 (2)
Wavelength (˚ A) 0.71073
Crystal system Monoclinic
Space group P21/c
Unit cell dimensions
a(˚ A) 14.6966(8)
b(˚ A) 7.3586(4)
c(˚ A) 14.0926(8)
α (◦) 90.00
β (◦) 94.358(5)
γ (◦) 90.00
Volume ( ˚ A3) 1519.66(15)
Z4
Calculated density (mg/m3) 1.309
Radiation type λ (˚ A) Mo K\a
F (000) 632
Crystal size (mm) 0.30 × 0.1 × 0.05
Crystal colour Light-yellow
Scan range θ (◦) 2.8–29.3
Absorption coeﬃcient (μ) (mm-1) 0.225
Max. and min. transm 1.00 and 0.419
Goodness of ﬁt on F2 0.995
Data/restrains/ parameters 3375/3/201
Final R indices [I > 2σ(I)] R1 = 0.0599, wR2 = 0.1324
R indices (all data) R1 = 0.110, wR2 = 0.1738
tin atom observed in the organotin(IV) complexes (2–6)
[33–36].
3.7. X-Ray Crystallography Diﬀraction Analysis. The molec-
ular structure of the ligand (1) with atom numbering
scheme is depicted in Figure 1. The main crystal parameters
are reported in Table 1. Selected bond lengths and bond
angles are given in Table 2. The compound crystallizes into
monoclinic crystal system with a space group of P21/c.
In the title substituted thiosemicarbazone, C16H17N3OS,
the hydroxy- and methyl-substituted benzene rings form
dihedral angles of 9.62 (12) and 55.69 (6)◦,r e s p e c t i v e l y ,
with the central CN3S chromophore (r.m.s. deviation =
0.0117 ˚ A)in(C16H17N3OS)(Figure 1)andtheOH–andMe-
benzene rings are twisted as seen in the respective dihedral
angles of 9.62 (12) and 55.69 (6)◦. The almost coplanarity
of the central atoms is ascribed to the formation of an
intramolecular hydroxyl-O–H··· N-imine hydrogen bond
(Table 3). The N1–N2 bond length (1.375 ˚ A) is closer to
single bond length (1.45 ˚ A) than to double bond length
(1.25 ˚ A) [37]. The C9–S1 bond distance (1.694 ˚ A) is close to
that expected of a C=S double bond (1.60 ˚ A) [37] and the
C7–N1bondlength(1.295 ˚ A)isnearlythesameasthatofthe6 Bioinorganic Chemistry and Applications
Table 2: Selected bond lengths (˚ A) and bond angles (◦) of ligand [H2dampt] (1).
Bond lengths (˚ A)
S1–C9 1.694 (3) O1–C1 1.357 (4)
N1–C7 1.295 (4) N1–N2 1.375 (3)
N2–C9 1.352 (4) N3–C9 1.344 (3)
C7–C8 1.500 (4) C6–C7 1.473 (4)
Bond angles (◦)
C7–N1–N2 119.0 (2) C9–N2–N1 120.6 (2)
C9–N3–C10 127.7 (2) N3–C9–N2 113.2 (2)
N3–C9–S1 124.3 (2) N2–C9–S1 122.4 (2)
O1–C1–C2 116.8 (3) O1–C1–C6 123.2 (3)
Table 3: Hydrogen-bond geometry (˚ A, ◦)
D-H···AD - HH ···AD ···AD - H···A
O1–H1o··· N1 0.84 (1) 1.81 (2) 2.551 (3) 145 (3)
N2–H2n··· S1i 0.88 (1) 2.51 (2) 3.323 (2) 154 (3)
N3–H3n··· S1i 0.88 (1) 2.49 (2) 3.286 (3) 151 (2)
C8–H8b···Cg1i 0.98 2.59 3.501 (3) 155
Symmetry codes: –x +1 ,y+1/2, –z +1 / 2 .
C1
O1
S1
N1
N2 N3
C2
C3
C4
C5
C6
C7
C8
C9 C10
C11
C12
C13
C14
C15
C16
Figure 1: The molecular structure of H2dampt (1) showing the
atom-labelling scheme and displacement ellipsoids at the 50%
probability level.
C=N double bond (1.28 ˚ A) [38]. These bond distances are in
strong support of the existence of 2-hydroxyacetophenone-
2-methylphenylthiosemicarbazo in the thione form in the
solid state. The H atoms of the NH groups are syn, and the
conformation about the N1=C7 double bond [1.295 (4) ˚ A]
is E.T h esyn arrangement in (C16H17N3OS)) contrast the
antiarrangement often seen in such derivatives but is readily
explained in terms of the intramolecular O–H···N-imine
hydrogen bond in (C16H17N3OS)) by contrast to the nor-
mally observed intramolecular N–H··· N-imine hydrogen
bond[39,40].Helicalsupramolecularchainsalongtheb axis
dominate the crystal packing (Figure 2 and Table 3). These
arise as a result of the thione-S interacting with both N–
H atoms of a neighboring molecule thereby forming six-
membered hydrogen-bond-mediated rings.
3.8. Antibacterial Activity. The synthesized ligand (1)a n d
its organotin(IV) complexes (2–6) were tested against
Figure 2: A view of the helical supramolecular chain aligned along
theb axisin(I).TheN–H···Shydrogenbondsareshownasorange
dashed lines. Further stabilization to the chain is provided by C–
H···π andπ–π interactions,shownasblueandpurpledashedlines,
respectively.
Escherichia coli, Staphylococcus aureus, Enterobacter aero-
genes,andSalmonellatyphibacterialstrainsfortheirantibac-
terial activity using agar-well diﬀusion method and data
are shown in Table 4 and Figure 3. The doxycycline was
used as a reference drug. The results showed that the
substituted thiosemicarbazone ligand (1) possessed mod-
erate antibacterial activity. The antibacterial studies of the
compounds (2–6) showed relatively better activity againstBioinorganic Chemistry and Applications 7
Table 4: Antibacterial activitya,b of the free ligand (1) and its organotin(IV) complexes 2–6 (inhibition zone in mm).
Bacterium Clinical implication Zone of Inhibition (mm)
(1) (2) (3) (4) (5) (6) R
Escherichia coli Infection of wounds, urinary tract, and dysentery 24 12 20 21 28 29 34
Staphylococcus aureus Food poisoning, scaled skin syndrome, endocarditis 14 22 24 — 29 30 36
Enterobacter aerogenes Lower respiratory tract infections, skin and soft-tissue infections — — 20 22 20 22 26
Salmonella typhi T y p h o i d f e v e r , l o c a l i z e d i n f e c t i o n 2 1—1 42 32 32 73 1
aIn vitro,a g a r - w e l ld i ﬀusion method, conc. 200mg/mL of DMSO. bReference drug (R), doxycycline, dash indicate inactivity.
0
5
10
15
20
25
30
35
40
1
2
3
4
5
6
R
Z
o
n
e
 
i
n
h
i
b
i
t
i
o
n
 
(
m
m
)
Bacteria
E. coli S. aureus E. aerogenes S. typhi
Figure 3: Antibacterial activity of compounds 1–6 against various
bacteria.
the selected bacteria than the free ligand (1), but low
activities as compared to the reference drug. Among all the
organotin(IV) derivatives, the bactericidal activities of 5 and
6 are fairly good. Complex 2 is the least active among all
the organotin(IV) complexes, while complex 4 was found to
be active against all the studied strains except Staphylococcus
aureus.Themostprobablereasonforthisdiﬀerencemightbe
due to chelation which reduces the polarity of the central Sn
atom because of the partial sharing of its positive charge with
donor groups and possible π-electron delocalization within
the whole chelating ring. As a result, the lipophilic nature of
the central Sn atom increases, which favours the permeation
ofthecomplexesthroughthelipidlayerofthecellmembrane
[41]. In addition, among the organotin(IV) complexes (2–
6), complex (6) is found to be more active and it can be
attributed to the presence of bulky phenyl groups which
facilate binding to biological molecules π-π interactions.
4. Conclusion
The ligand (1) and its organotin(IV) complexes (2–6)h a v e
been synthesized and fully characterized by diﬀerent spec-
troscopic techniques. The ligand (H2dampt) exists in thione
form in a solid state but it takes on a thiol form when it is
in solution. All organotin(IV) complexes (2–6)o fH 2dampt
were proposed to be ﬁve coordinated and the ligand binds
to the central tin(IV) atom in dinegative tridentate form.
Single crystal X-ray analysis of newly synthesized ligand (1)
has been reported. The in vitro antibacterial activities of the
synthesized complexes against the selected bacterial strains
have been established. All compounds have been found
biologically active, while the studies have conﬁrmed that
compounds 5 and 6 are more active and have the potency to
be used as antibacterial agents. Trials to obtain single crystals
suitableforstructuredeterminationbyX-raycrystallography
were in vain due to the amorphous nature of the complexes.
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